30 closest matches · ranked by relevance
Type 1 Diabetes Mellitus
Primary: Visual Analog Scale (VAS) Pain Score in the Abdominal, Arm, Thigh, and Buttock Areas — 3.4; 2.0; 1.8; 1.9 millimeter
Infiltration of Peripheral IV Therapy
Primary: Red Notification Sensitivity to Infiltrated Tissues — 99.0; 99.0 percentage of infiltrations detected
Infiltration of Peripheral IV Therapy
Primary: Red Notification Sensitivity to Infiltrated Tissues — 96.4 percentage of infiltrations
Infiltration of Peripheral IV Therapy
Primary: Time Infiltration Detected by Nurse — 29.8; 32.3 hours
Vascular Access Devices
Primary: IV Catheter Survival — 66; 55 Participants
Healthy
Primary: The Number of Injections With Local Site Reactions (Bleeding, Swelling, Bruising and Erythema). — 0; 51; 0; 0 injections
Acute Anterior Myocardial Infarction
Primary: Primary Endpoint - Infarct Size at 30 Days as a Percentage of Total Left Ventricular Mass - Abciximab Infusion vs. No Infusion — 15.1; 17.9; 17.2 Percentage of Left…
Infiltration of Peripheral IV Therapy
Primary: Normal Tissue Red Notification Rate — 0.24 red notifications per day
Intraosseous Vascular Access
Primary: Intraosseous Infusion Flow Rate — 2433.33 mL / hour
Infusion Site Injury
Primary: Percentage of PIVCs Sites With at Least One Clinical or Mechanical Complication (PIVC-related Complications) — 10; 6; 7 percentage of PIVC sites
Pressure Incidence Prevention
Primary: User Friendliness of Both Sacrum and Heel (Left & Right) Dressings: Comfort, Conformability, Acceptability, the Handling at Application and Ease of Inspection of the…
Catheter Infection · Catheter Thrombosis · Catheter Complications
Primary: Upper Extremity CR-UEVT — 7; 11 Participants
Indication for Peripheral Intravenous Catheterisation
Primary: Patent Indwell Time Between PIVCs of Different Length and Gauge. — 40.19; 42.96; 35.91; 36.91 hours
Pulmonary Hypertension · Pulmonary Arterial Hypertension
Primary: Pain Score on a Visual Analogue Scale — 2.89 Visual Analogue Scale — p=0.03
Pertrochanteric Fracture
Primary: Amount (mg) of Narcotics (Oral Morphine mg Equivalents) Used — 16; 10 morphine milligram equivalents (MME)
Port-A-Cath Placement · Octylcyanoacrylate
Primary: Number of Participants With Complication of Wound Dehiscence — 0; 0 participants
Donor Site Complication
Primary: Percentage of Participants Who Had > 95 % Epithelialization at Day 10 — 0 percentage of participants
PICC · Central Venous Catheter · Central Line
Primary: Participants With Complications With Central Access Including Insertion — 14; 10 Participants — p=0.271
Catheters · Catheterization, Peripheral
Primary: Number of Participants With First-skin Puncture Success — 244; 229 Participants
Diabetes Mellitus, Type 1 · Type 1 Diabetes
Primary: The Primary Endpoint is the Rate of Decline (s) Over Wear Time (DOI, Day 3, Day 5, Day 7) of the Natural Logarithm of the Area Under the Glucose Infusion Rate Curve [ln…
Thermal Burns
Primary: Narcotic Consumption (Measured in mg/kg Narcotic Consumption) — 57.5; 67.75 mg/kg narcotic consumption
Intravenous Infiltration
Primary: Number of Participants With Intraveneous Infiltration of FDG During Routine PET/CT Imaging by Visually Assessment of Interpreting Physicians — 17; 32 Participants
Dislodged Catheter · Catheter Related Complication
Primary: The Force (Newtons) Required to Dislodge an IV Catheter Secured in the Retrograde Direction. — 28.65; 15.41; 19.29 Newtons
Obstruction; Catheter, Infusion Catheter (Vascular) · Catheter; Complications (Indwelling Catheter)
Primary: Number of Participants With First Complete Occlusion Within 1 Year — 5; 4 Participants
Type 1 Diabetes Mellitus
Primary: Duration of Insulin Infusion Set Wear as a Measure of the Effect of Hyaluronidase Treatment — 5.7; 5.4 Days of wear
Healthy Volunteers
Primary: Presence of Cumulative Irritation — 163.0; 109.0; 2073.0 units on a scale
Arteriovenous Fistula Stenosis · Arteriovenous Fistula Occlusion · Arteriovenous Fistula
Primary: Target Lesion Primary Patency Rate Through 6 Months — 125; 88 Participants — p=<0.001
Diabetes Mellitus
Primary: Length of Wear of Infusion Site — 137; 145 hours
Post-operative Infections
Primary: Presence of Bacterial IV Stopcock Lumen Contamination — 41; 32 percent stopcock contamination rate
Fracture Fixation, Intramedullary · Surgical Wound Infection
Primary: Incidence of Surgical Site Infection (SSI) Relating to Intramedullary Nailing for Fixation of Diaphyseal Femoral and Tibial Fractures — 26; 195 Participants